Surgery Partners (SGRY) Competitors $25.75 0.00 (0.00%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$25.78 +0.02 (+0.10%) As of 01/30/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SGRY vs. HIMS, GH, OPCH, RDNT, BTSG, SHC, VCYT, LFST, CON, and PRVAShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Surgery Partners vs. Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Veracyte LifeStance Health Group Concentra Group Holdings Parent Privia Health Group Surgery Partners (NASDAQ:SGRY) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk. Do analysts prefer SGRY or HIMS? Surgery Partners presently has a consensus price target of $36.56, suggesting a potential upside of 41.96%. Hims & Hers Health has a consensus price target of $25.13, suggesting a potential downside of 25.83%. Given Surgery Partners' stronger consensus rating and higher possible upside, equities research analysts clearly believe Surgery Partners is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.35 Is SGRY or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Surgery Partners' net margin of -2.03%. Hims & Hers Health's return on equity of 10.97% beat Surgery Partners' return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-2.03% 2.85% 1.22% Hims & Hers Health 8.19%10.97%8.29% Which has more volatility & risk, SGRY or HIMS? Surgery Partners has a beta of 2.58, meaning that its stock price is 158% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Which has better earnings & valuation, SGRY or HIMS? Surgery Partners has higher revenue and earnings than Hims & Hers Health. Surgery Partners is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$2.74B1.19-$11.90M-$0.48-53.65Hims & Hers Health$872M8.49-$23.55M$0.4477.01 Does the media prefer SGRY or HIMS? In the previous week, Hims & Hers Health had 2 more articles in the media than Surgery Partners. MarketBeat recorded 19 mentions for Hims & Hers Health and 17 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.55 beat Hims & Hers Health's score of 0.39 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 4 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer SGRY or HIMS? Surgery Partners received 270 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 57.59% of users gave Surgery Partners an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformSurgery PartnersOutperform Votes31157.59% Underperform Votes22942.41% Hims & Hers HealthOutperform Votes4139.05% Underperform Votes6460.95% Do institutionals and insiders hold more shares of SGRY or HIMS? 63.5% of Hims & Hers Health shares are held by institutional investors. 2.3% of Surgery Partners shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryHims & Hers Health beats Surgery Partners on 10 of the 18 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.27B$11.64B$5.60B$9.14BDividend YieldN/A0.63%5.36%3.98%P/E Ratio-53.654.6089.7717.66Price / Sales1.190.611,211.9381.09Price / Cash11.346.8844.3437.71Price / Book1.0718.545.134.73Net Income-$11.90M$719.57M$118.85M$225.42M7 Day Performance26.72%4.86%1.46%0.75%1 Month Performance21.63%6.04%7.59%3.61%1 Year Performance-16.10%10.08%26.64%21.42% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners2.6714 of 5 stars$25.75flat$36.56+42.0%-17.7%$3.27B$2.74B-53.6513,500HIMSHims & Hers Health3.5373 of 5 stars$30.56-1.0%$25.13-17.7%+282.4%$6.65B$872M69.161,046Short Interest ↑GHGuardant Health3.7981 of 5 stars$47.00-0.4%$41.81-11.0%+124.3%$5.80B$563.95M-11.071,779Analyst ForecastShort Interest ↓Gap UpOPCHOption Care Health4.6175 of 5 stars$31.35+3.4%$32.25+2.9%-0.3%$5.34B$4.30B26.347,802Short Interest ↓Positive NewsRDNTRadNet3.4763 of 5 stars$63.71-0.6%$75.50+18.5%+80.3%$4.73B$1.62B-911.8310,288Short Interest ↑BTSGBrightSpring Health Services2.9237 of 5 stars$23.66+3.7%$18.65-21.2%+116.2%$4.11B$10.59B-90.7535,000Analyst ForecastShort Interest ↑Analyst RevisionSHCSotera Health3.4043 of 5 stars$13.89+1.7%$16.08+15.8%-4.6%$3.92B$1.05B55.423,000VCYTVeracyte3.9559 of 5 stars$42.98-1.9%$41.13-4.3%+79.3%$3.32B$361.05M-285.46790Analyst DowngradeNews CoverageLFSTLifeStance Health Group1.0301 of 5 stars$7.99+0.2%$8.70+9.0%+32.5%$3.06B$1.21B-30.719,325CONConcentra Group Holdings ParentN/A$23.55+0.1%$28.63+21.5%N/A$3.00B$1.84B0.0011,000PRVAPrivia Health Group3.6174 of 5 stars$22.87+1.3%$24.88+8.8%+11.0%$2.74B$1.72B228.021,102Positive News Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Veracyte Competitors LifeStance Health Group Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SGRY) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
